Cornercap Investment Counsel’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-34,873
Closed -$746K 660
2021
Q4
$746K Buy
+34,873
New +$687K 0.11% 369

Other funds holding OCDX

Cornercap Investment Counsel's OCDX Position: Q1 2022 in Review

Cornercap Investment Counsel sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 34,873 shares — an estimated $746K sold.

Cornercap Investment Counsel first reported a position in OCDX in Q4 2021 and held it in 1 quarter. The position peaked at $746K in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Cornercap Investment Counsel reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Cornercap Investment Counsel sold 34,873 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $746K.
  • Cornercap Investment Counsel first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • Cornercap Investment Counsel's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $746K in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Cornercap Investment Counsel's 13F filing for Q1 2022, filed 10 May 2022.